Login / Signup

Neoadjuvant cemiplimab induces durable complete response in locally advanced cutaneous squamous cell carcinoma.

Glenn GeidelLaura AdamAlessandra RüngerAnne MenzJulian KöttThomas HaalckChristoffer Gebhardt
Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Keyphrases
  • locally advanced
  • squamous cell carcinoma
  • rectal cancer
  • neoadjuvant chemotherapy
  • phase ii study
  • radiation therapy
  • lymph node metastasis
  • clinical trial
  • open label